Samrat Pharmachem share price
You have to be logged in to add this to Watchlist.Samrat Pharmachem is trading 2.73% upper at Rs 453.00 as compared to its last closing price. Samrat Pharmachem has been trading in the price range of 462.00 & 440.00. Samrat Pharmachem has given 26.64% in this year & -5.37% in the last 5 days.
Samrat Pharmachem has TTM P/E ratio 28.92 as compared to the sector P/E of 21.55.
The company posted a net profit of 2.66 Crores in its last quarter.
Listed peers of Samrat Pharmachem include Aarey Drugs & Pharmaceuticals (-3.58%), Source Natural Foods & Herb Supl (4.99%), Samrat Pharmachem (2.73%) etc.
Samrat Pharmachem has a 51.05% public holding. The FII holding in Samrat Pharmachem was at 3.24% in 30 Jun 2022. The FII holding has - from the last quarter.
Samrat Pharmachem share price range
|
| ||||
|
| ||||
Samrat Pharmachem share Key Metrics
| Market Cap ( ₹ Cr.) | 136.24 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Samrat Pharmachem Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 14-Nov-24 | Quarterly Results |
| 13-Aug-24 | Quarterly Results |
| 30-May-24 | Audited Results & Final Dividend |
| 14-Feb-24 | Quarterly Results |
| 08-Nov-23 | Quarterly Results |
| 14-Aug-23 | Quarterly Results |
| 30-May-23 | Audited Results & Dividend |
| 16-Mar-23 | Others |
| 14-Nov-22 | Quarterly Results |
| 13-Aug-22 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 26-Sep-24 | 30-May-24 | AGM |
| 10-Apr-24 | 05-Mar-24 | POM |
| 25-Sep-23 | 05-Sep-23 | AGM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 30-May-24 | 19-Sep-24 | 19-Sep-24 | 1 |
| 30-May-23 | 18-Sep-23 | 18-Sep-23 | 1 |
| 30-May-22 | - | 22-Sep-22 | 1 |
FAQs about Samrat Pharmachem share price
Samrat Pharmachem is trading at 453.00 as on Mon Nov 25 2024 09:56:49. This is 2.73% upper as compared to its previous closing price of 440.95.
The market capitalization of Samrat Pharmachem is 136.24 Cr as on Mon Nov 25 2024 09:56:49.
The 52 wk high for Samrat Pharmachem is 646.00 whereas the 52 wk low is 320.00
Samrat Pharmachem can be analyzed on the following key metrics -
- TTM P/E: 28.92
- Sector P/E: 21.55
- Dividend Yield: 0.23%
- D/E ratio: 0.13
Samrat Pharmachem reported a net profit of 2.16 Cr in 2024.
Samrat Pharmachem Quick Links
Samrat Pharmachem Dividend Samrat Pharmachem Bonus Samrat Pharmachem News Samrat Pharmachem AGM Samrat Pharmachem Rights Samrat Pharmachem Splits Samrat Pharmachem Board Meetings Samrat Pharmachem Key Metrics Samrat Pharmachem Shareholdings Samrat Pharmachem Profit Loss Samrat Pharmachem Balance Sheet Samrat Pharmachem Cashflow Samrat Pharmachem Q1 Results Samrat Pharmachem Q2 Results Samrat Pharmachem Q3 Results Samrat Pharmachem Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks